Shlomit Steinberg Koch

Shlomit fell in love with artificial intelligence when she developed an algorithm for Melanoma classification together with her graduation project partner, early in 2012.
During the next six years at Mazor Robotics (acquired by Medtronic) she led the neurosurgery robotic guided product to a commercial launch, led the development from ideation phase of a flagship software that enables surgeons to predict orthopedic surgeries outcomes and was also chosen to lead predictive analytics projects at Mazor’s innovation department. In that period of time she co-invented 3 pending approval patents.
Shlomit founded Predicta Med on January 2020, a digital health startup which aims to release the burden of autoimmune diseases from patients, payers and providers by harnessing the power of AI. Together with her team, she won first place at MedAboutData hackathon which is the first digital health competition in Israel who was led by huge firms such as Maccabi health, AstraZeneca, Teva, Technion, JVP ventures and ii2020. Predicta Med also won 3rd place at Coller’s competition for startups, led by Tel Aviv University.
Shlomit holds a BSc. in Biomedical Engineering from Ben Gurion University and an MBA in Entrepreneurship, Innovation and Technology Management from Tel Aviv University.
Founder and CEO of Predicta Med